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Abstract
The effect of gossypol on Ca2 signaling in Madin Darby canine kidney (MDCK) cells was investigated by using fura-2 as
a Ca2 probe. Gossypol evoked a rise in cytosolic free Ca2 levels ([Ca2]i) concentration-dependently between 2 and 20 WM.
The response was decreased by external Ca2 removal. In Ca2-free medium pretreatment with gossypol nearly abolished the
[Ca2]i increase induced by carbonylcyanide m-chlorophenylhydrazone (CCCP), a mitochondrial uncoupler, and
thapsigargin, an inhibitor of the endoplasmic reticulum Ca2 pump; but pretreatment with CCCP and thapsigargin only
partly inhibited gossypol-induced Ca2 release. Addition of 3 mM Ca2 induced a [Ca2]i increase after pretreatment with
5 WM gossypol in Ca2-free medium. This Ca2 entry was decreased by 25 WM econazole, 50 WM SKF96365 and 40 WM
aristolochic acid (a phospholipase A2 inhibitor). Pretreatment with aristolochic acid inhibited 5 WM gossypol-induced
internal Ca2 release by 55%, but suppression of phospholipase C with 2 WM 1-(6-((17L-3-methoxyestra-1,3,5(10)-trien-17-
yl)amino)hexyl)-1H-pyrrole-2,5-dione) had no effect. Gossypol (5 WM) also increased [Ca2]i in human bladder cancer cells
and neutrophils. Collectively, we have found that gossypol increased [Ca2]i in MDCK cells by releasing Ca2 from multiple
Ca2 stores in a manner independent of the production of inositol-1,4,5-trisphosphate, followed by Ca2 influx from external
space. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Gossypol, a polycyclic lipophilic agent naturally
present in cottonseed, has been known to be a potent
non-steroid antifertility agent in men and several
other mammalian species. Extensive trials of gossy-
pol as a male contraceptive has been conducted in
China [1]. This compound destroys elements of the
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seminiferous epithelium but does not alter the endo-
crine function of the testis. Infertility develops within
several months of its use and fertility is restored
within several months of discontinuation of the
drug. Unfortunately, gossypol causes serious side ef-
fects such as hypokalemia, weakness, diarrhea, ede-
ma, dyspnea, neuritis and paralysis. These side e¡ects
restrict the use of gossypol as a contraceptive in men
[2].
In vitro, gossypol has been shown to exert di¡er-
ent actions. These include alteration of secretory
function of cultured rat sertoli cells [3], arresting of
human benign prostatic hyperplastic cell growth at
the G0/G1 phase of the cell cycle [4], blockade of
cell-to-cell communication in human and rat cells
[5] and inhibition of swelling-induced chloride chan-
nels [6]. Moreover, evidence shows that gossypol in-
hibits human chorionic gonadotropin-stimulated tes-
tosterone production by cultured canine testicular
interstitial cells [7].
In addition, many other e¡ects are attributed to
gossypol. For example, depletion of ATP and inacti-
vation of an ATP-sensitive taurine channel [8], anti-
proliferative action on human breast cancer cells [9],
in vitro and in vivo cytotoxicity against central nerv-
ous system tumor cell lines [10], induction of apop-
totic DNA fragmentation and cell death in HL-60
cells [11] and blockade of aldose reductase from hu-
man placenta [12].
The e¡ect of gossypol on Ca2 signaling has not
been investigated previously. In this study we exam-
ined the e¡ect of gossypol on Ca2 signaling in Mad-
in Darby canine kidney cells (MDCK) cells. Previous
results showed that in this renal tubular cell, inositol
1,4,5-trisphosphate (IP3)-dependent agonists such as
ATP [13] and bradykinin [14] increase [Ca2]i by
depleting Ca2 from the endoplasmic reticulum
Ca2 store followed by an internal Ca2 re¢lling pro-
cess termed ‘capacitative Ca2 entry’ [15]. Also, thap-
sigargin [16] and 2,5-di-tert-butylhydroquinone [17]
increase [Ca2]i by inhibiting the endoplasmic retic-
ulum Ca2 pump without elevating IP3 levels, lead-
ing to a release of Ca2 from the endoplasmic retic-
ulum followed by capacitative Ca2 entry.
Here we show that gossypol induced an increase
in [Ca2]i in MDCK cells and two other cells: T24
human bladder cancer cells and human neutro-
phils.
2. Materials and methods
2.1. Cell culture
MDCK and T24 bladder carcinoma cells obtained
from the American Type Culture Collection (CRL-
6253) were cultured in Dulbecco’s modi¢ed Eagle
medium supplemented with 10% heat-inactivated fe-
tal bovine serum, 100 U/ml penicillin and 100 Wg/ml
streptomycin at 37‡C in 5% CO2-containing humidi-
¢ed air.
2.2. Isolation of human neutrophils
After obtaining informed consent, whole blood
was taken by venous puncture from a healthy human
volunteer with no history of infections 2 weeks be-
fore the experiments. Blood was mixed with heparin
(20 units/ml) and the erythrocytes were allowed to
sediment for 50 min at room temperature following
a 1:6 (v/v) Hespan:blood blend. The leukocyte-rich
plasma was harvested and centrifuged at 300Ug for
20 min. The supernatant was aspirated and centri-
fuged at 2170Ug for 15 min to produce platelet-
poor plasma. The pellet from centrifugation of leu-
kocyte-rich plasma was resuspended in 2.5 ml plate-
let-poor plasma and was transferred to a 15 ml tube,
where it was underlayered with 2 ml freshly prepared
42% Percoll in platelet-poor plasma. This mixture
was in turn underlayered with 2 ml of freshly pre-
pared 52% Percoll in platelet-poor plasma. The gra-
dients were centrifuged for 10 min at 280Ug. The
neutrophils were collected at the 42^51% Percoll in-
terface. The ¢nal cell population was determined to
contain s 95% neutrophils by Wright’s staining. The
neutrophils were 98% viable assayed by trypan blue
exclusion.
2.3. Solutions
Ca2 medium (pH 7.4) contained (in mM): 140
NaCl; 5 KCl; 1 MgCl2 ; 2 CaCl2 ; 10 HEPES and
5 glucose. Ca2-free medium contained no Ca2 plus
1 mM EGTA.
2.4. Optical measurements of [Ca2+]i
Trypsinized MDCK (or T24) cells and freshly iso-
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lated neutrophils (106/ml) were allowed to recover in
Dulbecco’s modi¢ed Eagle medium for 1 h before
being loaded with 2 WM 1-[2-(5-carboxyoxazol-2-
yl)-6-aminobenzofuran-5-oxy]-2-(2P-amino-5P-methyl-
phenoxy)-ethane-N,N,N,N-tetraacetic acid pentaace-
toxymethyl ester (fura-2/AM) for 30 min at 25‡C in
the same medium. The cells were washed and resus-
pended in Ca2 medium. Fura-2 £uorescence mea-
surements were performed in a water-jacketted cu-
vette (25‡C) with continuous stirring; the cuvette
contained 1 ml medium and 0.5 million cells. Fluo-
rescence was monitored with a Shimadzu RF-
5301PC spectro£uorophotometer by continuously re-
cording excitation signals at 340 and 380 nm and
emission signals at 510 nm at 1-s intervals. Maxi-
mum and minimum £uorescence values were ob-
tained by adding Triton X-100 (0.1%) and EGTA
(20 mM) sequentially at the end of an experiment.
[Ca2]i was calculated as described previously [18].
2.5. Chemical reagents
The reagents for cell culture were from Gibco.




yl)-2,5-pyrrolidine-dione (U73343) and aristolochic
acid were from Biomol. The other reagents were
from Sigma.
2.6. Statistical analysis
The traces were typical of 4^6 experiments. All
values were reported as means þ S.E.M. of 4^6 ex-
periments. Statistical comparisons were determined
by using Student’s paired t-test and signi¢cance was
accepted when P6 0.05.
3. Results
3.1. E¡ects of gossypol on [Ca2+]i
At concentrations between 2^20 WM, gossypol in-
creased [Ca2]i in the presence of Ca2 (Fig. 1A).
Over a time period of 5 min the responses were
monophasic but exhibited di¡erent velocities. For
example, at a concentration of 5 WM, gossypol in-
duced a nearly immediate increase in [Ca2]i fol-
lowed by a gradual rising phase which had a net
[Ca2]i of 320 þ 14 nM (trace b; n = 6; P6 0.05) at
the time point of 250 s. The increase of the Ca2
signal was slower in response to lower concentrations
of gossypol. The [Ca2]i response saturated at a con-
centration of 10 WM gossypol because 20 WM gossy-
pol did not induce a greater response (trace b versus
trace a; n = 5; Ps 0.05).
Fig. 1B shows that removal of external Ca2 re-
duced the Ca2 signals induced by 3^20 WM gossypol
and abolished the [Ca2]i increases induced by 2 WM
gossypol. The concentration^response plots of the
responses both in the presence and absence of exter-
nal Ca2 are illustrated in Fig. 1C. Ca2 removal
reduced the [Ca2]i increase induced by 3, 5, 10
and 20 WM gossypol by 87 þ 6, 85 þ 4, 82 þ 6 and
81 þ 3%, respectively, at the maximum value (n = 5^
6; P6 0.05).
3.2. The internal Ca2+ stores of gossypol-induced
[Ca2+]i increase
Fig. 2A shows that after pretreatment with 2 WM
CCCP, a mitochondrial uncoupler, and 1 WM thap-
sigargin, an endoplasmic reticulum Ca2 pump in-
hibitor [19], in Ca2-free medium to deplete the
Ca2 stores in mitochondria and the endoplasmic
reticulum, respectively, 5 WM gossypol still induced
a [Ca2]i increase with a net maximum value of
61 þ 5 nM (n = 5; P6 0.05). In contrast, Fig. 2B
shows that 5 WM gossypol induced a [Ca2]i increase
with a net maximum value of 120 þ 10 nM (n = 5;
P6 0.05). Subsequently added CCCP only induced
a tiny increase in [Ca2]i, and thapsigargin failed to
increase [Ca2]i.
3.3. E¡ect of gossypol on capacitative Ca2+ entry
In MDCK cells mobilization of internal Ca2
often results in capacitative Ca2 entry [13,14,
16,17]. Thus, the possibility that 5 WM gossypol in-
duced Ca2 in£ux via capacitative Ca2 entry was
tested. Capacitative Ca2 entry was measured by
adding 3 mM Ca2 to cells pretreated with gossypol
in Ca2-free medium. Fig. 2C shows that after deple-
tion of the internal Ca2 stores for 15 min with 5 WM
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gossypol, addition of Ca2 induced a [Ca2]i increase
with a net maximum value of 789 þ 21 nM (trace a;
n = 6) which was 39-fold higher than the control
(22 þ 3 nM; trace e; n = 6; P6 0.05).
The e¡ect of econazole and SKF96365, two inhib-
itors of capacitative Ca2 entry in MDCK cells
[20,21] and aristolochic acid, a phospholipase A2 in-
hibitor [22] on 5 WM gossypol-induced capacitative
Ca2 entry was explored. Fig. 2C shows that addi-
tion of econazole (25 WM; trace b), SKF96365
(50 WM; trace c) and aristolochic acid (40 WM; trace
d) 300 s prior to CaCl2 inhibited 5 WM gossypol-
induced capacitative Ca2 entry by 28 þ 4, 73 þ 8
and 82 þ 5%, respectively, in the net [Ca2]i value
at the time-point of 1100 s.
3.4. E¡ect of inhibiting phospholipase C or A2 on
gossypol-induced Ca2+ release
The question arose as to how gossypol releases
Ca2 from internal pools. The role of IP3 in the
response was examined. U73122, a phospholipase C
inhibitor [23], was used to suppress IP3 formation.
Previous studies have shown that ATP releases inter-
nal Ca2 in MDCK cells in an IP3-dependent man-
ner [24]. Fig. 3A, trace a, shows a typical [Ca2]i
increase induced by 10 WM ATP. Incubation with
U73122 (2 WM) for 210 s induced a small [Ca2]i
increase consistent with previous reports [24], but
prevented subsequently applied ATP (10 WM) from
increasing [Ca2]i (trace b; n = 6; P6 0.05). This
most likely suggested that U73122 had e¡ectively in-
hibited phospholipase C-dependent IP3 formation.
After U73122 pretreatment for 270 s, application of
5 WM gossypol induced a [Ca2]i increase with an
area under the curve (300^450 s) indistinguishable
from control (trace b versus trace c, 200 þ 12 versus
195 þ 5 arbitrary units, n = 6; Ps 0.05). U73343, an
inactive U73122 analogue, neither altered basal
[Ca2]i nor inhibited the [Ca2]i increases induced
by ATP and gossypol. Because aristolochic acid
was found to alter Ca2 £uxes in MDCK cells [25],
Fig. 1. (A) Concentration-dependent e¡ects of gossypol on
[Ca2]i. [Gossypol] = 20 WM in trace a, 10 WM in trace b, 5 WM
in trace c, 3 WM in trace d, 2 WM in trace e and 1 WM in trace
f. The experiments were performed in Ca2 medium. (B) Simi-
lar to (A) except that the cells were bathed in Ca2-free me-
dium. [Gossypol] = 20 WM in trace a, 5 WM in trace b, 3 WM in
trace c and 2 WM in trace d. (C) Concentration^response plots
of gossypol-induced Ca2 signals in the presence (¢lled circles)
or absence (open circles) of external Ca2. The y-axis is the
percentage of control response in terms of the maximum
[Ca2]i value. The control is the maximum value of [Ca2]i in-
crease induced by 10 WM gossypol in Ca2 medium. The data
are means þ S.E.M. of 5^6 experiments. *P6 0.05.
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Fig. 3. (A) E¡ect of U73122 on gossypol-induced internal Ca2
release. In Ca2-free medium, trace a: 10 WM ATP was added
at 30 s. Trace b: 2 WM U73122, 10 WM ATP and 5 WM gossy-
pol were added as indicated. Trace c: control e¡ect of gossypol.
(B) E¡ect of aristolochic acid on gossypol-induced internal
Ca2 release. Trace a: control e¡ect of 5 WM gossypol, added
at 250 s. Trace b: aristolochic acid (40 WM) was added at 30 s
followed by 5 WM gossypol at 250 s. (C) Gossypol-induced
[Ca2]i rises in human T24 bladder cancer cells and neutrophils.
Fig. 2. (A and B) Internal Ca2 sources of the gossypol-induced
[Ca2]i rise. (A) In Ca2-free medium, 2 WM CCCP, 1 WM
thapsigargin and 5 WM gossypol were added as indicated. (B)
In Ca2-free medium, 5 WM gossypol, 2 WM CCCP and 1 WM
thapsigargin were added as indicated. (C) Gossypol-induced ca-
pacitative Ca2 entry. Trace a: 5 WM gossypol was added at 30
s followed by 3 mM CaCl2 at 950 s. Traces b^d: similar to
trace a except that 25 WM econazole, 50 WM SKF96365 or 40
WM aristolochic acid were added 300 s prior to CaCl2, respec-
tively. Trace e: control CaCl2 e¡ect. CaCl2 was added as shown
without pretreatment with other drugs.
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its e¡ect on gossypol-induced Ca2 release was ex-
plored. Fig. 3B shows that pretreatment with aristo-
lochic acid (40 WM) for 250 s inhibited a 5 WM gos-
sypol-induced [Ca2]i increase by 55 þ 5% (n = 5;
P6 0.05) at the maximum value.
The e¡ect of gossypol on [Ca2]i in other cells was
investigated. Fig. 3C shows that 5 WM gossypol in-
duced a signi¢cant increase in [Ca2]i in T24 human
bladder cancer cells and human neutrophils with a
net maximum value of 581 þ 12 and 89 þ 5 nM (n = 6;
P6 0.05), respectively.
4. Discussion
Gossypol has been used as a non-steroid antifer-
tility agent in vivo, however the mechanism of its
action is unclear. The present study is the ¢rst to
show that gossypol increased [Ca2]i in intact cells.
Based on the data from Ca2-removal experiments,
gossypol appeared to increase [Ca2]i by both caus-
ing Ca2 in£ux and releasing internal Ca2, with the
former playing a major role.
Gossypol induced internal Ca2 release from Ca2
stores located in mitochondria, the endoplasmic re-
ticulum and other unidenti¢ed pools because this
drug still released some internal Ca2 after the
Ca2 stores in the endoplasmic reticulum and mito-
chondria had been discharged by thapsigargin and
CCCP, respectively. Consistently, gossypol was
shown to release Ca2 from rat liver mitochondria
[26]. MDCK cells do not appear to possess ryano-
dine-sensitive internal Ca2 stores because previous
reports demonstrated that neither ryanodine nor caf-
feine increased basal [Ca2]i [14].
Our ¢ndings suggest that gossypol induced exter-
nal Ca2 in£ux most likely via capacitative Ca2 en-
try, based on the Ca2 readmission experiment. This
hypothesis was supported by the data that econazole
and SKF96365 (two capacitative Ca2 entry inhibi-
tors) partly inhibited the gossypol-induced Ca2 in-
£ux.
It seems that IP3 did not play a dominant role in
gossypol-induced internal Ca2 release because the
Ca2 release was not altered when IP3 formation
was suppressed by U73122. Interestingly, aristolochic
acid, a phospholipase A2 inhibitor, was e¡ective in
inhibiting both gossypol-induced Ca2 release and
capacitative Ca2 entry, thus the possibility that
phospholipase A2 might have a regulatory role in
gossypol-induced [Ca2]i increase cannot be ex-
cluded.
Gossypol did not increase [Ca2]i in renal tubular
cells alone as it also did so in human bladder cancer
cells and neutrophils. Collectively, we have charac-
terized the [Ca2]i increase induced by gossypol in
MDCK cells and have investigated the underlying
mechanisms. Because altered Ca2 homeostasis
changes many cellular functions and prolonged
[Ca2]i increases might cause cytotoxicity, this study
addresses an important issue that gossypol may exert
its diverse in vivo and in vitro e¡ects through induc-
tion of marked [Ca2]i increases independent of oth-
er mechanisms and these e¡ects on [Ca2]i are often
overlooked in the process of data interpretation. Re-
searchers are cautioned to be aware of the ! !existence
of such e¡ects.
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